NDC codes

FDA NDC Directory
Product NDC (as listed)80725-243Labeler and product segments. Claims need a package NDC.
Product NDC at billing width80725-0243Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
80725-243-30807250243308072502433030 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (80725-243-30)Marketed from Dec 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Aciphex
Generic name (nonproprietary)
rabeprazole sodium
Active ingredients
Rabeprazole sodium — 20 mg/1
Dosage form
Tablet, Delayed release
Route
Oral
Labeler
Waylis Therapeutics LLCNDC labeler code 80725
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 020973
Marketing start
Listing expires
Other FDA classes
Proton Pump Inhibitors (Mechanism)
Identifiers
Product ID 80725-243_cc6cb214-ac28-4c8b-9b57-7635ef896038SPL ID cc6cb214-ac28-4c8b-9b57-7635ef896038SPL set ID 1eb38279-0237-4967-be7a-c53a826c1138RxCUI 854868, 854870UNII 3L36P16U4RUPC 0380725243303
Pharmacologic class
Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480725024330 followed by a unit qualifier and the quantity

Package 80725-0243-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

ACIPHEX delayed-release tablets is a proton pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) ( 1.1 ). Maintenance of Healing of Erosive or Ulcerative GERD ( 1.2 ). Treatment of Symptomatic GERD ( 1.3 ). Healing of Duodenal Ulcers ( 1.4 ). Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence ( 1.5 ). Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome ( 1.6 ). In adolescent patients 12 years of age and older for: Short-term Treatment of Symptomatic GERD ( 1.7 ). 1.1 Healing of Erosive or Ulcerative GERD in Adults ACIPHEX delayed-release tablets are indicated for sh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 80725-243

What is NDC 80725-243?
80725-243 is the product NDC for Aciphex (rabeprazole sodium), Rabeprazole sodium 20 mg/1 tablet, delayed release, listed with the FDA by Waylis Therapeutics LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Aciphex (Rabeprazole sodium).
What is the active ingredient?
Rabeprazole sodium.
Who is the labeler?
Waylis Therapeutics LLC, NDC labeler code 80725. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aciphex?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in